SecBot SecBot
6-K ·Filed May 19, 2026
AL

ALPWF

Alps Group Inc
BEARISH
Impact 7/10
Horizonmonths Processed5mo ago SEC0001493152-26-024418
Notable filing: 6-K
Actionable Insight ▼ Bearish

The stock is already trading on OTC markets (ALPWF), but the delisting risk from Nasdaq represents a material negative catalyst, as it signals deteriorating market confidence and potential forced reverse split. Monitor for reverse stock split announcement or capital raise as likely cure attempts — both are dilutive and negative for current holders. With no financial data in the filing, assess whether the company has sufficient cash runway to sustain operations through the compliance period.

DirectionBearish
Confidencehigh
Horizonmonths

Price Chart

Loading chart...

Executive Summary

Alps Group Inc (ALPWF) disclosed a Nasdaq bid price deficiency notice received May 15, 2026, for its ordinary shares trading below $1.00 for 30 consecutive business days. The company has until November 11, 2026 to regain compliance, with a potential additional 180-day cure period if it meets other listing standards. Failure to cure could lead to delisting, creating material downside risk for the stock.

Key Facts

  • Nasdaq notified Alps Group on May 15, 2026 that its bid price was below $1.00 for 30 consecutive business days
  • Initial compliance period ends November 11, 2026 (180 calendar days)
  • Potential second 180-day cure period if company meets market value of publicly held shares and other initial listing standards
  • Delisting risk if compliance is not achieved through reverse stock split or price recovery

Financial Impact

Nasdaq delisting would severely impair liquidity and access to public equity markets for this OTC-traded biotechnology holding company

liquiditymarket accessshare price

Risk Factors

  • Delisting if bid price fails to exceed $1.00 by November 2026 or end of extended compliance period
  • Forced reverse stock split to regain compliance, which is typically viewed negatively by the market
  • Possible inability to meet other Nasdaq listing requirements during the cure period
  • Stock may face further selling pressure as delisting deadline approaches

Market Snapshot

Exchange
OTC
Sector
Services-Health Services

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001493152-26-024418
Exhibit: ex99-1.htm0001493152-26-024418
Document: 0001493152-26-024418-index-headers.html0001493152-26-024418
Document: 0001493152-26-024418-index.html0001493152-26-024418
Document: 0001493152-26-024418.txt0001493152-26-024418
3 reports for ALPWF
Performance horizon
Filters
Rows
Reports for ALPWF — sortable, filterable
TypeNow
Jun 9, 2026
20w ago
6-K
NEUTRAL ★ 4/10
—awaiting T+20——
May 19, 2026
22w ago
6-K
BEARISH ★ 7/10
—awaiting T+20——
Apr 17, 2026
27w ago
6-K
NEUTRAL ★ 3/10
—awaiting T+20——
Showing 3 of 3

US Market Status

Market Open — Closes in 2h 50m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 19, 2026